Abstract
Alpha synuclein picobodies, which are N-terminal truncations of alpha synuclein nanobodies are provided. Methods of using alpha synuclein picobodies for diagnosing and treating synucleinopathies are also provided.
| Original language | English |
|---|---|
| Patent number | US2024052022 |
| IPC | G01N 33/ 68 A I |
| Priority date | 14/08/23 |
| Publication status | Published - 15 Feb 2024 |